Oculis Holding AG (Oculis Holding AG) Total Payout Yield % : -7.77 (As of Jun. 20, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Oculis Holding AG's current Total Payout Yield % is -7.77%.

Oculis Holding AG Total Payout Yield % Historical Data

The historical data trend for Oculis Holding AG's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Total Payout Yield % Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Payout Yield %

-38.10

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Payout Yield %	Get a 7-Day Free Trial							-173.15	-37.75	-	-	-

Competitive Comparison of Oculis Holding AG's Total Payout Yield %

For the Biotechnology subindustry, Oculis Holding AG's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oculis Holding AG's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oculis Holding AG's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Oculis Holding AG's Total Payout Yield % falls into.

Oculis Holding AG Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Oculis Holding AG's Total Payout Yield % for the fiscal year that ended in Dec. 2023 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Market Cap
	=	- (0	+	156.817	+	0)	/	411.576131
	=	-38.10%

Oculis Holding AG's annualized Total Payout Yield % for the quarter that ended in Mar. 2024 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0	+	0)	*	4	/	442.720615
	=	0.00%

Oculis Holding AG Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.

Oculis Holding AG Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG (Oculis Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (NAS:OCS) » Definitions » Total Payout Yield %

Comparable Companies

Traded in Other Exchanges

OCS:Iceland

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.